Nonetheless, we were able to show a striking effect of reducing Fbxl17 expression on at least one important cancer-relevant pathway, in a relevant cell type, suggesting that inactivation of Fbxl17 would have a major effect on the cancer cell. This evidence concerns the gene FBXL17 and cancer.